pharmacie et médicaments – Prise en charge mélatonine, syndrome Smith Magenis, pour les majeurs

This written question asks about the coverage of melatonin for adults diagnosed with Smith-Magenis syndrome. It seeks clarification on the conditions and procedures for reimbursement. The question concerns patients with a specific genetic disorder and their access to necessary medication. It aims to ensure appropriate healthcare provision for affected adults.